ST生物(000504.SZ):董事長金文泉辭職
格隆匯 10 月 22日丨ST生物(000504.SZ)公佈,公司董事會於2020年10月21日收到金文泉的書面辭職報告,金文泉因個人原因申請辭去公司董事及董事長職務,以及董事會戰略委員會主任委員、提名委員會和審計委員會委員職務、下屬各子公司的一切職務。辭職後,金文泉不再擔任公司及公司全資、控股子公司任何職務。金文泉的辭呈自提交董事會之日起生效。
根據《公司章程》相關規定,經公司第十屆董事會全體董事同意,推舉董事胡榮尚代為履行董事長職務,代行公司法定代表人職責,期限自2020年10月22日起至新任董事長選舉產生之日止。公司董事會將按照法定程序儘快完成公司董事、董事長的補選等相關後續工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.